Christence Stubbe Teglbjærg

A Randomized, Placebo-Controlled Study of the Effects of Denosumab for the Treatment of Men with Low Bone Mineral Density

Eric Orwoll, Christence Stubbe Teglbjærg, Bente Langdahl et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 231 citations · Full text

Medicine, Pharmacotherapy, Bone Metabolism +16

Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study

Stuart L. Silverman, Arkadi Chines, David L. Kendler et al. · Osteoporosis International · 2011 · 164 citations

Medicine, Pharmacotherapy, Bone Metabolism +12

A 24-Month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density: Results From the ADAMO Trial

Bente Langdahl, Christence Stubbe Teglbjærg, Pei‐Ran Ho et al. · The Journal of Clinical Endocrinology & Metabolism · 2015 · 134 citations · Full text

Medicine, Pharmacotherapy, Bone Augmentation +16

Denosumab Significantly Increases DXA BMD at Both Trabecular and Cortical Sites: Results From the FREEDOM Study

Michael A. Bolognese, Christence Stubbe Teglbjærg, José Zanchetta et al. · Journal of Clinical Densitometry · 2012 · 64 citations

Medicine, Pharmacology, Molecular Imaging +4

Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1–31)NH2] in postmenopausal women with osteoporosis

Kim Henriksen, J.R. Andersen, B.J. Riis et al. · Bone · 2012 · 53 citations

Medicine, Pharmacokinetics, Pharmacology +14